<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">465804519</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180323112100.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170327e19900301xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF03349551</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF03349551</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Hyperprolactinemia and temporal lobe epilepsy in a woman: concomitant and persistent prolactin suppression and temporal lobe epilepsy relief</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[A. Gattereau, J. Vézina, S. Rousseau, P. Bielmann]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">It has been reported that hyperprolactinemia may be associated with increased temporal lobe activity. Coexisting hyperprolactinemia (97.5 ± 3.2 ng/ml) related to a pituitary tumefaction (8 mm) and Temporal Lobe Epilepsy (TLE), were observed in a 37-year-old woman. Carbamazepin (CBZ) therapy induced a marked improvement in TLE symptoms and EEG recordings, but did not influence hyperprolactinemia and related symptoms. Long-lasting (27 months) normoprolactinemia (19.4 ± 0.6 ng/ml) and TLE relief were achieved on a dopamine (DA) agonist medication, e.g. pergolide mesylate, 25-50 μg/day given over 8 months, and persisted as long as 27 months after drug withdrawal. Posttreatment CT scans showed progressive shrinkage of the pituitary tumor (2 mm) associated with an empty-sella. It is proposed that, whenever TLE and hyperprolactinemia coexist, therapy with a DA agonist such as pergolide mesylate, resulting in normoprolactinemia, may be beneficial in TLE control.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Italian Society of Endocrinology (SIE), 1990</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Prolactinoma</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">hyperprolactinoma</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">TLE</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">pergolide mesylate</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Gattereau</subfield>
   <subfield code="D">A.</subfield>
   <subfield code="u">Sections of Endocrinology, Neuro-Radiology and Gynaecology, Hôpital Hôtel-Dieu and Université de Montréal, 3840 St-Urbain, H2W 1T8, Montréal, Québec, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Vézina</subfield>
   <subfield code="D">J.</subfield>
   <subfield code="u">Sections of Endocrinology, Neuro-Radiology and Gynaecology, Hôpital Hôtel-Dieu and Université de Montréal, 3840 St-Urbain, H2W 1T8, Montréal, Québec, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Rousseau</subfield>
   <subfield code="D">S.</subfield>
   <subfield code="u">Sections of Endocrinology, Neuro-Radiology and Gynaecology, Hôpital Hôtel-Dieu and Université de Montréal, 3840 St-Urbain, H2W 1T8, Montréal, Québec, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Bielmann</subfield>
   <subfield code="D">P.</subfield>
   <subfield code="u">Sections of Endocrinology, Neuro-Radiology and Gynaecology, Hôpital Hôtel-Dieu and Université de Montréal, 3840 St-Urbain, H2W 1T8, Montréal, Québec, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Journal of Endocrinological Investigation</subfield>
   <subfield code="d">Springer International Publishing</subfield>
   <subfield code="g">13/3(1990-03-01), 247-249</subfield>
   <subfield code="x">0391-4097</subfield>
   <subfield code="q">13:3&lt;247</subfield>
   <subfield code="1">1990</subfield>
   <subfield code="2">13</subfield>
   <subfield code="o">40618</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF03349551</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF03349551</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Gattereau</subfield>
   <subfield code="D">A.</subfield>
   <subfield code="u">Sections of Endocrinology, Neuro-Radiology and Gynaecology, Hôpital Hôtel-Dieu and Université de Montréal, 3840 St-Urbain, H2W 1T8, Montréal, Québec, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Vézina</subfield>
   <subfield code="D">J.</subfield>
   <subfield code="u">Sections of Endocrinology, Neuro-Radiology and Gynaecology, Hôpital Hôtel-Dieu and Université de Montréal, 3840 St-Urbain, H2W 1T8, Montréal, Québec, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Rousseau</subfield>
   <subfield code="D">S.</subfield>
   <subfield code="u">Sections of Endocrinology, Neuro-Radiology and Gynaecology, Hôpital Hôtel-Dieu and Université de Montréal, 3840 St-Urbain, H2W 1T8, Montréal, Québec, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Bielmann</subfield>
   <subfield code="D">P.</subfield>
   <subfield code="u">Sections of Endocrinology, Neuro-Radiology and Gynaecology, Hôpital Hôtel-Dieu and Université de Montréal, 3840 St-Urbain, H2W 1T8, Montréal, Québec, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Journal of Endocrinological Investigation</subfield>
   <subfield code="d">Springer International Publishing</subfield>
   <subfield code="g">13/3(1990-03-01), 247-249</subfield>
   <subfield code="x">0391-4097</subfield>
   <subfield code="q">13:3&lt;247</subfield>
   <subfield code="1">1990</subfield>
   <subfield code="2">13</subfield>
   <subfield code="o">40618</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
